By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Researchers pinpoint what happens on a cellular and molecular level over time when the cancer is treated with either ...

Brahmer: Immunotherapy is approved for the first-line treatment of patients with metastatic lung cancer who have high levels of PDL-1. PDL-1 is a protein some lung cancers release to prevent the ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients treated with immunotherapy, are the main reason certain immunotherapies ...

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery. by University of Texas M. D. Anderson Cancer Center ...

Combining immunotherapy with chemotherapy nearly doubled the survival time of non-small cell lung cancer patients compared to patients treated with chemotherapy alone, new research shows.

Lung cancer: AI shows who will benefit from immunotherapy By Maria Cohut, Ph.D. on November 25, 2019 — Fact checked by Paula Field Lung cancer is a common and often aggressive form of cancer.

Learn more about what the research says about immunotherapy for small cell lung cancer (SCLC), including efficacy, clinical trials, and combination with other treatments.

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Immunotherapy is not appropriate for every patient with lung cancer. As the decision to give immunotherapy is made in conversation with the patient and the physician, some of the things that ...